News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
526,106 Results
Type
Article (40836)
Company Profile (120)
Press Release (485135)
Multimedia
Podcasts (138)
Webinars (18)
Section
Business (150903)
Career Advice (1789)
Deals (22525)
Drug Delivery (96)
Drug Development (60568)
Employer Resources (113)
FDA (11334)
Job Trends (10794)
News (248170)
Policy (21874)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2542)
Academic (2)
Accelerated approval (35)
Adcomms (26)
Allergies (130)
Alliances (42168)
ALS (192)
Alzheimer's disease (1793)
Antibody-drug conjugate (ADC) (357)
Approvals (11703)
Artificial intelligence (678)
Autoimmune disease (245)
Automation (44)
Bankruptcy (188)
Best Places to Work (8862)
BIOSECURE Act (18)
Biosimilars (149)
Biotechnology (91)
Bladder cancer (159)
Brain cancer (83)
Breast cancer (649)
Cancer (4965)
Cardiovascular disease (376)
Career advice (1547)
Career pathing (39)
CAR-T (252)
CDC (40)
Celiac Disease (1)
Cell therapy (739)
Cervical cancer (36)
Clinical research (52357)
Collaboration (1948)
Company closure (5)
Compensation (551)
Complete response letters (51)
COVID-19 (2144)
CRISPR (98)
C-suite (876)
Cystic fibrosis (114)
Data (6815)
Decentralized trials (3)
Denatured (49)
Depression (149)
Dermatology (68)
Diabetes (460)
Diagnostics (5001)
Digital health (43)
Diversity (8)
Diversity, equity & inclusion (31)
Drug discovery (350)
Drug pricing (130)
Drug shortages (23)
Duchenne muscular dystrophy (212)
Earnings (66303)
Editorial (58)
Employer branding (14)
Employer resources (100)
Events (80570)
Executive appointments (829)
FDA (14328)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1476)
Gene editing (192)
Generative AI (67)
Gene therapy (620)
GLP-1 (821)
Government (3262)
Grass and pollen (6)
Guidances (363)
Healthcare (14187)
HIV (66)
Huntington's disease (51)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (70)
Immunology and inflammation (197)
Immuno-oncology (76)
Indications (166)
Infectious disease (2388)
Inflammatory bowel disease (183)
Inflation Reduction Act (12)
Influenza (88)
Intellectual property (233)
Interviews (332)
IPO (10952)
IRA (38)
Job creations (2261)
Job search strategy (1266)
JPM (55)
Kidney cancer (15)
Labor market (71)
Layoffs (336)
Leadership (38)
Legal (5258)
Liver cancer (71)
Longevity (24)
Lung cancer (650)
Lymphoma (364)
Machine learning (52)
Management (40)
Manufacturing (788)
MASH (158)
Medical device (8975)
Medtech (9056)
Mergers & acquisitions (12548)
Metabolic disorders (1167)
mRNA (161)
Multiple sclerosis (171)
NASH (11)
Neurodegenerative disease (414)
Neuropsychiatric disorders (85)
Neuroscience (3198)
Neurotech (2)
NextGen: Class of 2026 (4808)
Non-profit (3899)
Now hiring (31)
Obesity (510)
Opinion (273)
Ovarian cancer (186)
Pain (212)
Pancreatic cancer (243)
Parkinson's disease (359)
Partnered (31)
Patents (442)
Patient recruitment (529)
Peanut (41)
People (42290)
Pharmaceutical (20)
Pharmacy benefit managers (18)
Phase 1 (16696)
Phase 2 (22769)
Phase 3 (17270)
Pipeline (7647)
Policy (237)
Postmarket research (2077)
Preclinical (7585)
Press Release (60)
Prostate cancer (286)
Psychedelics (51)
Radiopharmaceuticals (259)
Rare diseases (873)
Real estate (3805)
Recruiting (47)
Regulatory (17455)
Reports (34)
Research institute (2439)
Resumes & cover letters (250)
Rett syndrome (35)
RNA editing (21)
RSV (61)
Schizophrenia (155)
Series A (251)
Series B (157)
Service/supplier (5)
Sickle cell disease (92)
Special edition (18)
Spinal muscular atrophy (142)
Sponsored (39)
Startups (2622)
State (1)
Stomach cancer (11)
Supply chain (82)
Tariffs (47)
The Weekly (88)
Vaccines (836)
Venture capital (85)
Weight loss (306)
Women's health (91)
Worklife (18)
Date
Last 7 days (526)
Last 30 days (2579)
Last 365 days (23805)
2026 (10386)
2025 (23882)
2024 (26830)
2023 (30079)
2022 (38500)
2021 (40915)
2020 (39268)
2019 (34526)
2018 (25746)
2017 (24059)
2016 (23601)
2015 (27162)
2014 (22248)
2013 (19483)
2012 (19709)
2011 (19434)
2010 (18164)
Location
Africa (716)
Alabama (85)
Alaska (6)
Arizona (200)
Arkansas (12)
Asia (31339)
Australia (5567)
California (10152)
Canada (2887)
China (1147)
Colorado (440)
Connecticut (510)
Delaware (371)
Europe (72526)
Florida (1589)
Georgia (330)
Hawaii (1)
Idaho (41)
Illinois (765)
India (80)
Indiana (512)
Iowa (17)
Japan (478)
Kansas (102)
Kentucky (46)
Louisiana (28)
Maine (44)
Maryland (1274)
Massachusetts (7432)
Michigan (270)
Minnesota (485)
Mississippi (4)
Missouri (127)
Montana (24)
Nebraska (15)
Nevada (105)
New Hampshire (54)
New Jersey (2963)
New Mexico (26)
New York (2825)
North Carolina (1271)
North Dakota (8)
Northern California (5157)
Ohio (274)
Oklahoma (19)
Oregon (26)
Pennsylvania (2031)
Puerto Rico (13)
Rhode Island (32)
South America (966)
South Carolina (47)
South Dakota (1)
Southern California (4031)
Tennessee (175)
Texas (1673)
United States (36577)
Utah (301)
Vermont (1)
Virginia (239)
Washington D.C. (65)
Washington State (827)
West Virginia (4)
Wisconsin (94)
Wyoming (2)
526,106 Results for "brain and behavior discovery institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Foundation for the National Institutes of Health Announces Recipients of the Deeda Blair Research Initiative for Disorders of the Brain
May 20, 2026
·
4 min read
Press Releases
Feinstein Institutes’ Scientists Discover Brain Circuit That Links Inflammation and Stress Response
February 27, 2026
·
5 min read
Press Releases
The world’s largest brain research prize awarded for groundbreaking discoveries on how we sense touch and pain
March 5, 2026
·
3 min read
Press Releases
AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation
May 13, 2026
·
4 min read
Press Releases
Brain Cancer Canada Awards The Dwayne Andrews Glioblastoma Research Grant to Tackle One of the Most Aggressive Brain Tumours and Unlock Immunotherapy Breakthroughs for Young Patients
May 21, 2026
·
4 min read
Press Releases
Feinstein Institutes research finds early brain warning signs in severe liver damage
March 3, 2026
·
3 min read
Press Releases
Feinstein Institutes’ Dr. Stephanie Fitzpatrick elected Fellow of the Academy of Behavior Medicine Research
February 5, 2026
·
3 min read
Press Releases
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer’s Disease Program
• Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical Trials • Consistent Anti-Inflammatory Effects Demonstrate Translation from Animal Models to Three-Dimensional Human Brain Tissue Systems
March 23, 2026
·
7 min read
Job Trends
Innovation Pressure Cooker: Tackling Drug Discovery’s Biggest Challenges
Drug discovery can be an uphill battle, especially lately given recent upheaval at the FDA and muted investment activity.
BioSpace
spoke to four industry executives about key issues facing those working in this space, starting with planning around uncertainty.
April 2, 2026
·
5 min read
·
Angela Gabriel
Insights
The New Gold Rush in Brain Science
Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, even amid costly setbacks.
BioSpace
spoke to investors at JPM26 to get their take on recent bets in new therapies and neurotech.
January 22, 2026
·
5 min read
·
Jennifer C. Smith-Parker
1 of 52,611
Next
